Cases & Deals

Baxalta invests in OncoResponse

Clients Baxalta Inc.

Jones Day represented Baxalta Inc., a biopharmaceutical manufacturer headquartered in Northern Illinois, in connection with its purchase of Series A Convertible Preferred Stock in a private placement by OncoResponse, an immuno-oncology antibody discovery company.